Government
Jul. 30, 2003
In the Balance
Forum Column - By Norm Kjono - Should pharmaceutical companies widely distribute nonsmoked nicotine products that are highly addictive and inherently harmful to consumers? Would it be appropriate to statutorily exempt these manufacturers from liability? What would the probable effect of such actions be on the value of the $18 billion in tobacco-settlement bonds that the states have issued to investors?




&n...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In